Evolent Health, Inc. EVH Non-current Restricted Cash and Cash Equivalents
Non-current Restricted Cash and Cash Equivalents at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s non-current restricted cash and cash equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s non-current restricted cash and cash equivalents?
- Evolent Health, Inc. (EVH) reported non-current restricted cash and cash equivalents of $2.74M in Q1 2026.
- How has Evolent Health, Inc.'s non-current restricted cash and cash equivalents changed year-over-year?
- Evolent Health, Inc.'s non-current restricted cash and cash equivalents decreased by 81.8% year-over-year, from $15.06M to $2.74M.
- What is the long-term trend for Evolent Health, Inc.'s non-current restricted cash and cash equivalents?
- Over 5 years (2020 to 2025), Evolent Health, Inc.'s non-current restricted cash and cash equivalents has grown at a -16.5% compound annual growth rate (CAGR), from $6.65M to $2.71M.
- What does non-current restricted cash and cash equivalents mean?
- This represents cash and cash equivalents held by the company that are subject to legal or contractual restrictions preventing their use for general corporate purposes for a period exceeding one year. It often reflects collateral requirements, escrow arrangements, or regulatory mandates tied to long-term obligations. Monitoring this balance helps investors assess the portion of liquidity that is effectively locked away from operational deployment.